Related Experiment Video
Updated: Jul 20, 2025

Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice
Published on: January 24, 2025
Decoding the role of leptin and adiponectin in obesity-related gastrointestinal cancer
Vanda Marques1, Fabiola Arella1,2, Marta B Afonso1
1Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.
Abstract:
The increasing prevalence of obesity brings forward its importance as a risk factor for cancer development, particularly in the gastrointestinal tract. Obesity may trigger cancer development through several mechanisms, where metabolic deregulation of adipokines can modulate multiple oncogenic molecular pathways. Leptin and adiponectin are the most well-studied adipokines, and their imbalance can trigger different tumorigenic responses. Both epidemiologic and experimental studies have associated leptin with increased cancer risk and cell responsiveness in carcinogenesis and tumor invasion. On the other hand, adiponectin is reported to elicit the opposite effect. In addition to circulating or tissue adipokine levels, adiponectin, and leptin receptors or genetic polymorphisms may also play a role in cancer development. Moreover, adiponectin and leptin modulation offer valuable therapeutic approaches. We will review the links underpinning obesity and cancer development and focus on discussing the pathophysiological roles of leptin and adiponectin.
More Related Videos
Related Concept Videos
Regulation of Food Intake
Obesity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Prevention
Some...
Psychoneuroimmunology: Diabetes and Cancer
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

